Our Mission
Ace Vision Group’s (AVG) Mission is to be the leader in developing innovative touchless Microporation Therapeutics for the aging eye.
We are providing eye care professionals with innovative devices, procedures, and education for the prevention and recovery of age-related vision loss.
Company Overview
Ace Vision Group, Inc, (“AVG” or “the Company”) is an emerging ophthalmic laser device company bringing innovative touchless Eye Laser Therapy to patients suffering from age-related vision loss.
AnnMarie Hipsley, DPT, PhD
AnnMarie Hipsley, DPT, PhD
Alex Lopez
Alex Lopez
Val Kolesnitchenko, MD
Val Kolesnitchenko, MD
Frank L. Chen, BS, MBA
Frank L. Chen, BS, MBA
Frank L. Chen is the Chief Operating Officer (COO) of Ace Vision Group.
Before being named COO in June 2024, Frank was President of Santen Ventures, Inc., where he was responsible for operations, business development and investments in best-in-class biotech startups. He has invested in various companies and achieved multiple exits.
Beginning his career in clinical care, Frank witnessed the transformative impact of new therapies on patient lives and knew he wanted to spend his career around innovation. This inspired him to spend nearly a decade at Johnson & Johnson in medical device development, honing his expertise in lean six sigma. He then transitioned to business consulting, assisting top pharmaceutical companies with technology transformation, digital marketing, and commercial readiness.
As a former board member for Ace Vision Group and seeing the life-changing impact of Laser Scleral Microporation Therapy, Frank decided to return to Ace Vision Group in order to help bring this innovative technology to patients.
Frank holds a B.S. in physiology and neurology from the University of California, San Diego and an MBA from the University of Southern California, Marshall School of Business.
David Lin, MD, FRCSC
David Lin, MD, FRCSC
Dr. Lin has expertise in refractive lasers, algorithms and experience in the medical device industry. As CMA, he will help drive Ace Vision Group's device development, the company said in a statement. After medical training at McGill University in Montreal, Canada, followed by an ophthalmology residency, Dr. Lin completed two years of postgraduate corneal training at Pacific Medical Consultants in San Francisco and Louisiana State University (LSU) in New Orleans.
In 1989, Dr. Lin returned to Vancouver and set up one of the first excimer laser centers in Canada, where he has been specializing in laser refractive procedures.
Joseph Carroll
Joseph Carroll
Robert Lundberg
Robert Lundberg
Dave Neal
Dave Neal
Eddie Hsiao, PhD
Eddie Hsiao, PhD
AnnMarie Hipsley, DPT, PhD
AnnMarie Hipsley, DPT, PhD
Jim Simms
Jim Simms
Joseph Carroll
Joseph Carroll
Jay Joliat
Jay Joliat
Rob Hadley
Rob Hadley
Ken Araki
Ken Araki
Mitchell Jackson, MD
Mitchell Jackson, MD
Robert Ang, MD
Robert Ang, MD
Elizabeth Yeu, MD
Elizabeth Yeu, MD
Sheri Rowen, MD, FACS
Sheri Rowen, MD, FACS
Steven Silverstein, MD, FACS
Steven Silverstein, MD, FACS
Karolinne Maia Rocha, MD, PhD
Karolinne Maia Rocha, MD, PhD
William Wiley, MD
William Wiley, MD
Ehsan Sadri, MD, FACS
Ehsan Sadri, MD, FACS
James Katz, MD
James Katz, MD
Cathleen McCabe, MD
Cathleen McCabe, MD
Dagny Zhu, MD
Dagny Zhu, MD
Dr. Dagny Zhu, MD, is a board-certified ophthalmologist specializing in cornea, cataract, and refractive surgery. She graduated Summa Cum Laude from UCLA with a full tuition Regent’s Scholarship and received her MD from Harvard Medical School. She then completed her residency at USC/Doheny Eye Institute and her fellowship in cornea and refractive surgery at Bascom Palmer. She is currently Medical Director and Partner at NVISION Eye Centers in Rowland Heights, California and also serves as Clinical Preceptor in Ophthalmology for Western University College of Osteopathic Medicine and clinical faculty for the Los Angeles County + University of Southern California Department of Ophthalmology. Dr. Zhu serves as medical advisor to multiple ophthalmic companies, lectures to her peers nationally and worldwide, and leads cutting-edge clinical research studies in presbyopia-correcting technologies. She has been featured in over 300 presentations, publications, and press features including Forbes, The Today Show, and CNN.